Aesica
Serialisation services have been introduced for a multinational client’s two anti-allergy product lines at Aeisca’s manufacturing and packaging site in Pianezza, Italy. The packaging lines and associated serialisation services are for one of Aesica’s strategic partners’ dedicated supply to the Chinese market. The implementation took under six months to complete.
The joint collaboration called for Aesica personnel at Pianezza to use their knowledge and skills to deliver serialisation packaging methods and processes that fully comply with stringent State Food and Drug Administration regulations set by the Ministry of Health of China and dovetailed with the partner’s coding requirements. As a consequence of the partnership, Aesica is one of the first CDMOs in Italy to have successfully implemented serialisation for a pharmaceutical product.
The serialisation technology uses special digital techniques to check the linear barcode 128 and 20 digit serialised numbers. The code check is in full compliance with international ISO 15416 standards. The check system provides a reliable instrument for checking products and batches all the way through the packaging and distribution process.
The platform has capability for both thermal transfer and thermal ink jet printers for printing stickers with e-codes and variable data with 2D bar codes respectively. According to Aesica, high quality variable programming, inks suitable for a multiplicity of applications and ribbons that comply with the latest legislative and environmental standards have all been part of the installation.
Paolo Pizzorni, senior director at Aesica Pianezza, commented: “We are delighted that our strategic partnership model has seen the successful development of two robust serialisation packaging lines. For our customer, this means improved patient safety with a reduced risk of competition from counterfeit products and the ability to detect expired drugs automatically. The end-users are now able to verify the integrity and authenticity of the products dispensed to patients using a simple scan.”
He added: “China is a key geographic market that Western pharma companies seek to export to. We are delighted to be providing serialisation services to enable one of our customers to meet the technical and complex serialisation regulations in this market.”
Aesica Pharmaceuticals Ltd, www.aesica-pharma.com.